Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - pharmaceuticals
Novel compounds for treatment for Friedreich Ataxia
New compounds identified through high throughput screening which improve mitochondrial function of Friedreich ataxia cells. Technology Overview: Friedreich ataxia (FA) is an autosomal recessive, inherited neuro- and cardio-degenerative disorder characterized by progressive ataxia of all four limbs, skeletal deformities, and hypertrophic cardiomyopathy....
Therapeutics & Vaccines
© 2020. All Rights Reserved. Powered by